Breaking News

ICON Appoints Metabolic Research Head

By Kristin Brooks | January 20, 2014

Dr. Elahi brings 30 years of research experience

Dr. Dariush Elahi has been appointed director of Metabolic Research at ICON plc. Dr. Elahi will lead ICON’s early phase glucose clamping programs globally, providing scientific consultation to sponsors developing therapeutics to treat endocrine/metabolic disease. He’ll be based in the company’s Clinical Pharmacology Unit in San Antonio, TX.
Dr. Elahi is a clinical physiologist with more than 30 years of research experience focused on translational investigations of the regulation of glucose homeostasis. His expertise includes kinetics analyses of fuel substrates using both stable and radioactive tracers and the employment of these techniques during clamp studies. Dr. Elahi has authored 147 scientific publications and is nationally and internationally recognized for his work on the role of insulin. He has served as a professor at The Johns Hopkins University School of Medicine, Harvard Medical School, and the University of Pennsylvania’s Perelman School of Medicine. He also served as Research Physiologist and Senior Staff Fellow at the National Institutes of Health (NIH) and National Institutes on Aging.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks